Allergies News and Research

Latest Allergies News and Research

Dry cracked skin of eczema patients promotes 'atopic march'

Infants who develop eczema are more likely to develop food allergies, hay fever and asthma as they grow older, a progression known as the atopic march.

17 Jul 2019

Novel vaccine against bee sting allergy successfully tested

A recently completed trial on a bee sting vaccine containing a novel adjuvant called Advax to increase its efficacy has raised hopes that severe allergic reactions, sometimes fatal, to bee venom in allergic people could soon be a thing of the past. The vaccine was designed to neutralize the venom of the European honeybee.

17 Jul 2019

New app created to help people reduce exposure to anticholinergic medications

A team of researchers from Indiana University School of Medicine, Regenstrief Institute and Purdue University, led by Richard Holden, PhD, is testing a new app, called Brain Safe, designed to help people reduce their exposure to a common class of drugs linked to Alzheimer's disease.

15 Jul 2019

Scripps CHAVD wins $129 million NIH grant to advance new HIV vaccine approach

The Scripps Consortium for HIV/AIDS Vaccine Development, an international collaboration led by Scripps Research, has received a $129 million grant from the National Institutes of Health to advance next-generation vaccines designed to coax the immune system into producing antibodies capable of disarming numerous strains of HIV.

11 Jul 2019

PerkinElmer unveils CE-marked infectious disease immunoassays on EUROIMMUN random access instrument

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the first two CE-marked chemiluminescence immunoassays (ChLIA) for the detection of anti-Borrelia (Lyme disease) and anti-EBV/EBNA (Epstein-Barr Virus) antibodies on its EUROIMMUN RA Analyzer 10 system.

From Revvity 11 Jul 2019

UM scientists receive $3.3 million NIH contract to develop opioid addiction vaccine

The University of Montana has received a $3.3 million contract from the National Institutes of Health to develop an innovative vaccine targeting opioid addiction.

10 Jul 2019

Novel method can help clinicians identify individuals most in need of PrEP

Researchers have demonstrated the effectiveness of using algorithms that analyze electronic health records to help physicians identify patients at risk for HIV who may benefit from preexposure prophylaxis, which significantly reduces the risk of getting HIV.

9 Jul 2019

Antibiotic combination effective against drug-resistant Pseudomonas

Two well known and used antibiotics when combined have been found to be more effective against a deadly bacteria Pseudomonas aeruginosa, a common cause of hospital-based infections.

8 Jul 2019

Study shows potential culprit behind Lupus

A team of researchers at the Emory University School of Medicine show that patients with SLE or lupus, have abnormal activation of B cells, which is part of the body’s immune system

8 Jul 2019

Common antibacterial agent may be bad news for bone health

The antibacterial agent triclosan has been linked with an increased risk for osteoporosis among females in the US, particularly postmenopausal women.

4 Jul 2019

Computer-generated flu vaccine enters clinical trials in the US

A seasonal flu vaccine that has been developed entirely by artificial intelligence on a computer is set to be tested in clinical trials in the US.

4 Jul 2019

Researchers synthesize artificial cells to detect histamine

Baking a cake from scratch is a task deemed difficult for many. Constructing an artificial cell-like system from scratch, well that's another story.

3 Jul 2019

State broadens investigation of doctors for issuing questionable vaccination exemptions

The California agency that regulates doctors is investigating at least four physicians for issuing questionable medical exemptions to children whose parents did not want them immunized.

2 Jul 2019

Georgia State researcher wins $3.26 million federal grant to develop universal flu vaccine

Influenza remains a major public health risk, and Dr. Baozhong Wang, associate professor in Georgia State University's Institute for Biomedical Sciences, has received a five-year, $3.26 million federal grant to combat this threat by developing a universal vaccine that offers more protection against influenza than seasonal vaccines.

2 Jul 2019

$3.1 million NIH funding awarded to develop universal flu vaccine

In the race to create a universal flu vaccine not dependent on predicting strains of flu, the Virginia-Maryland College of Veterinary Medicine's Department of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources has been awarded a $3.1 million grant.

1 Jul 2019

More effective flu vaccine begins clinical trials across the U.S.

A more effective seasonal flu vaccine is about to be tested in clinical trials across the US.

1 Jul 2019

Study explores long-term impact of food restrictions on normal eating patterns in patients

Celiac disease, irritable bowel syndrome, crohn's disease and anaphylactic are all instigated by food allergies.

29 Jun 2019

New target identified for treatment of idiopathic pulmonary fibrosis

An article published in Experimental Biology and Medicine (Volume 244, Issue 9, June 2019) (https://journals.sagepub.com/doi/pdf/10.1177/1535370219843827) identifies a new target for the treatment of idiopathic pulmonary fibrosis.

29 Jun 2019

Comprehensive gene activity database could significantly reduce animal use

A comprehensive database of gene activity in mice across ten disease models, which could significantly reduce animal use worldwide, has been developed by scientists at the Francis Crick Institute, which gives a full picture of the immune response to different pathogens.

29 Jun 2019